Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease ...
Q1 2026
May 8, 2026
FY 2025
Mar 23, 2026
Q4 2025
Q3 2025
Nov 7, 2025
Q2 2025
Aug 8, 2025